Dr. Casulo on Predicting Outcomes in Follicular Lymphoma

Video

Carla Casulo, MD, discusses several different factors that can help predict outcomes in patients with follicular lymphoma.

Carla Casulo, MD, associate professor, Department of Medicine, University of Rochester Medical Center, discusses several different factors that can help predict outcomes in patients with follicular lymphoma.

At the time of diagnosis, the Follicular Lymphoma International Prognostic Index (FLIPI) and FLIPI2 scores can assist physicians in predicting response to therapy. In addition, epigenetic markers can be combined with clinical factors to predict whether patients will have worse or better outcomes; this is called the M7FLIPI.

<<< 2019 International Congress on Hematologic Malignancies

Related Videos
Pasi A. Jänne, MD, PhD, discusses an exploratory analysis from the FLAURA2 trial of osimertinib plus chemotherapy in treatment-naive, EGFR-mutant NSCLC.
Eric S. Christenson, MD
Samer A. Srour, MB ChB, MS
Rebecca L. Porter, MD, PhD
Deborah J. Wong, MD, PhD
Michael R. Migden, MD
Patrick I. Borgen, MD
Kari Hacker, MD, PhD, NYU Grossman School of Medicine
Janos L. Tanyi, MD, PhD, associate professor, Obstetrics and Gynecology, Hospital of the University of Pennsylvania
Reshma Lillaney Mahtani, DO